Targeted protein degradation accelerates drug discovery, but traditional proximity assays can introduce artifacts. LifeSensors’ TUBE platform directly measures compound-induced ubiquitination in vitro, cells, and tissues—enabling rapid PROTAC/molecular glue discovery, including a potent K-RAS target. Tech include assay reagents, kits, and CRO work.